These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37266270)

  • 1. Retracted: Integrated Analysis of the Roles of RNA Binding Proteins and Their Prognostic Value in Clear Cell Renal Cell Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9828737. PubMed ID: 37266270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retracted: Elevated Plasma Interleukin-35 as a Prognostic Indicator in Localized Clear Cell Renal Cell Carcinoma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9846548. PubMed ID: 37387965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retracted: Identification of Differentially Methylated Genes Associated with Clear Cell Renal Cell Carcinoma and Their Prognostic Values.
    Environmental And Public Health JO
    J Environ Public Health; 2023; 2023():9756067. PubMed ID: 38125879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: A New Survival Model Based on Cholesterol Biosynthesis-Related Genes for Prognostic Prediction in Clear Cell Renal Cell Carcinoma.
    International BR
    Biomed Res Int; 2024; 2024():9838460. PubMed ID: 38550156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Clear Cell Renal Cell Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2022; 2022():9807439. PubMed ID: 36475012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retracted] LncRNA GAS6 antisense RNA 1 facilitates the tumorigenesis of clear cell renal cell carcinoma by regulating the AMP‑activated protein kinase/mTOR signaling pathway.
    Guo X; Li H; Zhang M; Li R
    Oncol Lett; 2024 Mar; 27(3):126. PubMed ID: 38333641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: Comprehensive Analysis of Regulatory Network for LINC00472 in Clear Cell Renal Cell Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9864232. PubMed ID: 37829402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: The Function and Prognostic Value of RNA-Binding Proteins in Colorectal Adenocarcinoma Were Analyzed Based on Bioinformatics of Smart Medical Big Data.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9896539. PubMed ID: 37266289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9780837. PubMed ID: 37829649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: Prognostic Value of Stem Cell Index-Related Characteristics in Primary Hepatocellular Carcinoma.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9850917. PubMed ID: 37502512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Identification of the HMMR Gene as a Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9819147. PubMed ID: 37808149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: Clinical Study on the Efficacy of Microwave Ablation (MA) in the Treatment of Stage I Renal Clear Cell Carcinoma by CT and MRI Imaging.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9862864. PubMed ID: 37476775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted: Screening of Differentially Expressed Iron Death-Related Genes and the Construction of Prognosis Model in Patients with Renal Clear Cell Carcinoma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9823636. PubMed ID: 37885864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: Effects of CIK Cell Therapy Combined with Camrelizumab on the Quality of Life in Patients with Nasopharyngeal Carcinoma and Analysis of Prognostic Factors.
    Neuroscience CIA
    Comput Intell Neurosci; 2022; 2022():9854614. PubMed ID: 36601276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: Comprehensive and Integrated Analysis Identifies ZEB1 as a Key Novel Gene in Oral Squamous Cell Carcinoma.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9783040. PubMed ID: 37502536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: Construction of an Immune-Autophagy Prognostic Model Based on ssGSEA Immune Scoring Algorithm Analysis and Prognostic Value Exploration of the Immune-Autophagy Gene in Endometrial Carcinoma (EC) Based on Bioinformatics.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9834327. PubMed ID: 37860371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: Identification of Novel Biomarkers Related to Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9780526. PubMed ID: 38094439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9754067. PubMed ID: 37501844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: Identification of Paxillin as a Prognostic Factor for Glioblastoma via Integrated Bioinformatics Analysis.
    International BR
    Biomed Res Int; 2023; 2023():9762109. PubMed ID: 38075323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: Hub Gene Screening and Prognostic Modeling of Lung Cancer: An Integrated Bioinformatics Study.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9834087. PubMed ID: 37475946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.